Coloplast A Stock Today
| CLPBY Stock | USD 12.51 0.15 1.21% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Coloplast is trading at 12.51 as of the 25th of November 2024; that is 1.21% up since the beginning of the trading day. The stock's open price was 12.36. Coloplast has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on June 8, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Coloplast A's common stock.
Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.. The company has 2.12 B outstanding shares. More on Coloplast A
Moving against Coloplast Pink Sheet
Coloplast Pink Sheet Highlights
| President | Alain Morvan |
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Coloplast A [CLPBY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 24.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Coloplast A classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 2.12 B outstanding shares.
Coloplast A has accumulated about 854 M in cash with 5.1 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Check Coloplast Probability Of Bankruptcy
Ownership AllocationColoplast holds a total of 2.12 Billion outstanding shares. Almost 99.99 percent of Coloplast outstanding shares are held by general public with 0.01 % by other corporate entities. On June 8, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Coloplast A's common stock.
Check Coloplast Ownership Details
Coloplast A Risk Profiles
| Mean Deviation | 1.18 | |||
| Standard Deviation | 1.42 | |||
| Variance | 2.02 | |||
| Risk Adjusted Performance | (0.06) |
Coloplast Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Coloplast without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.